| Literature DB >> 27872811 |
Bengi Baran1, F Işık Karahanoğlu1, Yigal Agam1, Leonidas Mantonakis2, Dara S Manoach1.
Abstract
Deficits in the adaptive, flexible control of behavior contribute to the clinical manifestations of schizophrenia. We used functional MRI and an antisaccade paradigm to examine the neural correlates of cognitive control deficits and their relations to symptom severity. Thirty-three chronic medicated outpatients with schizophrenia and 31 healthy controls performed an antisaccade paradigm. We examined differences in recruitment of the cognitive control network and task performance for Hard (high control) versus Easy (low control) antisaccade trials within and between groups. We focused on the key regions involved in 'top-down' control of ocular motor structures - dorsal anterior cingulate cortex, dorsolateral and ventrolateral prefrontal cortex. In patients, we examined whether difficulty implementing cognitive control correlated with symptom severity. Patients made more errors overall, and had shorter saccadic latencies than controls on correct Hard vs. Easy trials. Unlike controls, patients failed to increase activation in the cognitive control network for Hard vs. Easy trials. Reduced activation for Hard vs. Easy trials predicted higher error rates in both groups and increased symptom severity in schizophrenia. These findings suggest that patients with schizophrenia are impaired in mobilizing cognitive control when presented with challenges and that this contributes to deficits suppressing prepotent but contextually inappropriate responses, to behavior that is stimulus-bound and error-prone rather than flexibly guided by context, and to symptom expression. Therapies aimed at increasing cognitive control may improve both cognitive flexibility and reduce the impact of symptoms.Entities:
Keywords: Anterior cingulate cortex; Antisaccade; Cognitive control; Functional MRI; Prefrontal cortex; Schizophrenia
Mesh:
Year: 2016 PMID: 27872811 PMCID: PMC5109850 DOI: 10.1016/j.nicl.2016.10.020
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Participant characteristics. Means, standard deviations and group comparisons of demographic data.
| Schizophrenia patients | Healthy controls | |||||
|---|---|---|---|---|---|---|
| mean | SD | mean | SD | t | ||
| Age | 43 | 12 | 41 | 13 | 0.69 | 0.49 |
| Sex | 7F/26M | 7F/24M | Χ2 = 0.02 | 0.89 | ||
| Parental Education | 14 | 3 | 14 | 3 | 0.39 | 0.69 |
| Laterality Score (Handedness) | 61 | 45 | 67 | 55 | − 0.49 | 0.63 |
| Estimated Verbal IQ | 98 | 16 | 101 | 28 | 0.52 | 0.61 |
| PANSS Total | 59 | 13 | ||||
| PANSS Positive | 15 | 4 | ||||
| PANSS Negative | 14 | 5 | ||||
| PANSS General | 31 | 7 | ||||
| SANS | 24 | 16 | ||||
| Age at Onset | 24 | 7 | ||||
| Duration of illness (years) | 19 | 13 | ||||
| CPZ Equivalents | 482 | 386 | ||||
Abbreviations: PANSS = Positive and Negative Syndrome Scale; SANS = Scale for the Assessment of Negative Symptoms; CPZ = Chlorpromazine.
Based on the modified Edinburgh Handedness Inventory(Oldfield, 1971, White and Ashton, 1976). Laterality scores of − 100 and + 100 denote exclusive use of left or right hand, respectively.
Based on standard scores on the reading subtest of the Wide Range Achievement Test (WRAT-III; Wilkinson, 1993).
Antipsychotic drug dosage measured in chlorpromazine equivalents (Woods, 2003).
Fig. 1Antisaccade paradigm. Schematic and timeline of the three trial types: Easy, Hard and Fake-Hard. Each trial lasted for 4 s and began with a cue informing the participant of either an Easy or Hard trial. The cue was either a blue or a yellow “X” and the mapping of cue color to trial type was counterbalanced across participants. The cue was flanked horizontally by two small white squares with a width of 0.4° that marked the potential locations of stimulus appearance: 10° left and right of center. These squares remained visible for the duration of each run. At 300 ms, the instructional cue was replaced by a white fixation ring at the center of the screen, with a diameter of 1.3°. At 1800 ms, the central fixation ring disappeared (200 ms gap), and at 2000 ms, it reappeared on either the right or left side as the imperative stimulus to which participants were required to respond. Hard trials were distinguished by an increase in luminance of both the peripheral squares that mark the potential locations of stimulus appearance during the gap and the imperative stimulus. Except for the hard cue, Fake-Hard trials were identical to Easy trials. In the trials depicted, the correct response was a saccade away from the stimulus on the left side of the display. An error would involve a saccade toward the stimulus. After 1 s, the fixation ring returned to the center. Participants were instructed to return their gaze to the center and fixate until another trial began. Fixation intervals, which lasted 2, 4, or 6 s, were simply a continuation of the fixation display that constitutes the final second of the previous saccadic trial.
Fig. 2Antisaccade task performance. (A) Error rate and (B) latency of correct antisaccades for Hard, Easy and Fake-Hard trials. Error bars show standard error of the mean. (C) The relationship between SANS negative symptom severity and the difference in latency for Easy minus Hard trials in schizophrenia patients.
Fig. 3Group activation differences in cognitive control regions and relations with errors and symptoms. (A) Statistical maps of group differences at 6 s for Hard vs. Easy trials displayed on the inflated right cortical surface of the template brain at p ≤ 0.01 (Monte Carlo corrected). Greater activation in healthy controls (HC) is depicted in warm colors. Anatomical boundaries for dACC, DLPFC and VLPFC are outlined in green. (B) Hemodynamic responses for significant clusters: Hard vs. Easy (top row); Hard, Easy and Fake-Hard trials vs. fixation in healthy controls (HC; middle row) and patients (SZ; bottom row). The 6 s time point is highlighted. (C) Relations of activation with errors. Scatterplots show the relations between logit transformed error rate and activation for dACC, DLPFC and VLPFC clusters showing group differences. Blue circles and dashed regression lines represent controls, red circles and solid regression lines represent patients. (D) Relations of activation with symptom severity in schizophrenia. Scatterplots show the relations of symptom severity as indexed by PANSS total score with activation for dACC, DLPFC and VLPFC clusters showing group differences.